MSACW (Medicus Sciences Acquisition) 5-Year Yield-on-Cost %: 0.00 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MSACW Medicus Sciences Acquisition Corp MSACW
24 GF Score
Price $0.00
! 1 Warning Sign
View Full Analysis

What is Medicus Sciences Acquisition 5-Year Yield-on-Cost %?

Medicus Sciences Acquisition MSACW 24 5-Year Yield-on-Cost % is 0.00 as of Sep. 09, 2026. GuruFocus rates MSACW with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.

Medicus Sciences Acquisition's yield on cost for the quarter that ended in Sep. 2022 was 0.00.


The historical rank and industry rank for Medicus Sciences Acquisition's 5-Year Yield-on-Cost % or its related term are showing as below:



MSACW's 5-Year Yield-on-Cost % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 4.31
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Medicus Sciences Acquisition  (NAS:MSACW) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Medicus Sciences Acquisition 5-Year Yield-on-Cost % Related Terms

MSACW vs GENQ, DUET, AIB: 5-Year Yield-on-Cost % Comparison

For the Shell Companies subindustry, Medicus Sciences Acquisition's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicus Sciences Acquisition 5-Year Yield-on-Cost % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Medicus Sciences Acquisition's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Medicus Sciences Acquisition's 5-Year Yield-on-Cost % falls into.


MSACW
24GF Score
Medicus Sciences Acquisition Corp MSACW
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicus Sciences Acquisition 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Medicus Sciences Acquisition is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Medicus Sciences Acquisition (MSACW) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medicus Sciences Acquisition and its competitors.
Is Medicus Sciences Acquisition's 5-Year Yield-on-Cost % too high?
Medicus Sciences Acquisition's current 5-Year Yield-on-Cost % is 0.00. Overall, Medicus Sciences Acquisition has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Sciences Acquisition's 5-Year Yield-on-Cost % compare to GENQ and DUET?
Medicus Sciences Acquisition's 5-Year Yield-on-Cost % of 0.00 can be compared against companies in the Diversified Financial Services industry. The industry median 5-Year Yield-on-Cost % is 4.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Diversified Financial Services company?
The median 5-Year Yield-on-Cost % among Diversified Financial Services companies is 4.31, based on 46 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medicus Sciences Acquisition and its competitors. For the Diversified Financial Services industry, the median 5-Year Yield-on-Cost % is 4.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicus Sciences Acquisition's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Sciences Acquisition stock overvalued right now?
Medicus Sciences Acquisition (MSACW) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Medicus Sciences Acquisition's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medicus Sciences Acquisition (MSACW), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Sciences Acquisition Business Description

Address 152 West 57th Street, Floor 20, New York, NY, USA, 10019
Medicus Sciences Acquisition Corp is a blank check company.
24GF Score

Get the complete analysis for MSACW

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price